Vincenzo Marzolla

Mineralocorticoid receptor antagonism induces browning of white adipose tissue through impairment of autophagy and prevents adipocyte dysfunction in high‐fat‐diet‐fed mice

Andrea Armani, Francesca Cinti, Vincenzo Marzolla et al. · The FASEB Journal · 2014 · 156 citations

Antiadipogenic Effects of the Mineralocorticoid Receptor Antagonist Drospirenone: Potential Implications for the Treatment of Metabolic Syndrome

Massimiliano Caprio, Antonella Antelmi, Gérard S. Chetrite et al. · Endocrinology · 2010 · 134 citations · Full text

Metabolic Disorder, Potential Implications, Pharmacotherapy +22

Essential role of ICAM-1 in aldosterone-induced atherosclerosis

Vincenzo Marzolla, Andrea Armani, Caterina Mammi et al. · International Journal of Cardiology · 2017 · 116 citations · Full text

Inflammation, Vascular Disease, Molecular Physiology +8

Macrophage NCOR1 protects from atherosclerosis by repressing a pro-atherogenic PPARγ signature

Sara Oppi, Stefanie Nusser‐Stein, Przemysław Błyszczuk et al. · European Heart Journal · 2019 · 95 citations · Full text

The novel non‐steroidal MR antagonist finerenone improves metabolic parameters in high‐fat diet‐fed mice and activates brown adipose tissue via AMPK‐ATGL pathway

Vincenzo Marzolla, Alessandra Feraco, Stefania Gorini et al. · The FASEB Journal · 2020 · 64 citations

Metabolic Disorder, Oxidative Stress, Obesity +19